Procept Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Procept Biorobotics Corp
PRCT Stock  USD 30.38  0.12  0.39%   
Analyzing historical trends in various income statement and balance sheet accounts from Procept Biorobotics' financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Procept Biorobotics' valuation are summarized below:
Gross Profit
193.6 M
Profit Margin
(0.28)
Market Capitalization
1.7 B
Enterprise Value Revenue
4.9423
Revenue
299.9 M
There are currently one hundred twenty trending fundamental ratios for Procept Biorobotics Corp that can be evaluated and compared over time across competitors. All traders should check out Procept Biorobotics' recent fundamentals against the performance from 2010 to 2026 and make sure the trends continue to evolve in the right direction.

Procept Biorobotics Total Revenue

271.08 Million

Check Procept Biorobotics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Procept Biorobotics' main balance sheet or income statement drivers, such as Net Interest Income of 8.1 M, Interest Income of 13.2 M or Depreciation And Amortization of 3.6 M, as well as many indicators such as Price To Sales Ratio of 20.42, Dividend Yield of 0.0 or PTB Ratio of 18.47. Procept financial statements analysis is a perfect complement when working with Procept Biorobotics Valuation or Volatility modules.
  
Build AI portfolio with Procept Stock
Check out the analysis of Procept Biorobotics Correlation against competitors.

Procept Biorobotics Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets325.1 M614.1 M192.4 M
Slightly volatile
Short and Long Term Debt Total67.6 M92.3 M43.4 M
Slightly volatile
Other Current Liabilities17.5 M34 M11.4 M
Slightly volatile
Total Current Liabilities31.5 M61.1 M19.2 M
Slightly volatile
Total Stockholder Equity485.7 M462.6 M144 M
Slightly volatile
Other Liabilities171 K180 K825.4 K
Slightly volatile
Property Plant And Equipment Net28.7 M52.5 M18.3 M
Slightly volatile
Current Deferred Revenue11.5 M11 M2.5 M
Slightly volatile
Accounts Payable6.9 M11.5 M4.1 M
Slightly volatile
Cash231 M383.8 M132.5 M
Slightly volatile
Non Current Assets Total33.3 M60 M22.3 M
Slightly volatile
Non Currrent Assets Other3.1 M2.9 M850.7 K
Slightly volatile
Other Assets1.091.15679.6 K
Pretty Stable
Long Term Debt49.8 M59.2 M34.7 M
Slightly volatile
Cash And Short Term Investments231 M383.8 M132.5 M
Slightly volatile
Net Receivables100.8 M96 M21.2 M
Slightly volatile
Common Stock Shares Outstanding42 M59.9 M37.2 M
Slightly volatile
Liabilities And Stockholders Equity325.1 M614.1 M192.4 M
Slightly volatile
Non Current Liabilities Total66.7 M90.5 M44.4 M
Slightly volatile
Inventory67.8 M64.6 M20.3 M
Slightly volatile
Other Current Assets10.2 M9.7 M2.9 M
Slightly volatile
Other Stockholder Equity1.1 B1.1 B297.6 M
Slightly volatile
Total Liabilities98.2 M151.6 M63.6 M
Slightly volatile
Property Plant And Equipment Gross30.8 M61.5 M19.7 M
Slightly volatile
Total Current Assets291.8 M554.1 M170 M
Slightly volatile
Net Working Capital260.4 M493 M151.1 M
Slightly volatile
Short Term Debt2.3 M1.7 M2.9 M
Slightly volatile
Intangible Assets1.3 M838.8 K1.9 M
Slightly volatile
Property Plant Equipment38.8 M37 M16.2 M
Slightly volatile
Short and Long Term Debt3.6 M4.1 M4.5 M
Slightly volatile
Capital Surpluse422.9 M475.8 M519.3 M
Slightly volatile
Deferred Long Term Liabilities1.2 M1.3 M1.5 M
Slightly volatile
Non Current Liabilities Other381.7 K372.6 K265.4 K
Slightly volatile

Procept Biorobotics Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Interest Income13.2 M12.5 M3.3 M
Slightly volatile
Depreciation And Amortization3.6 M6 M2.5 M
Slightly volatile
Interest Expense4.6 M4.8 M2.4 M
Slightly volatile
Selling General Administrative207 M197.1 M67.8 M
Slightly volatile
Total Revenue271.1 M258.2 M62.9 M
Slightly volatile
Other Operating Expenses387.7 M369.3 M124.7 M
Slightly volatile
Research Development75.2 M71.6 M26.7 M
Slightly volatile
Cost Of Revenue105.5 M100.5 M29.7 M
Slightly volatile
Total Operating Expenses282.2 M268.8 M95.1 M
Slightly volatile
Reconciled Depreciation3.5 M6 M2.5 M
Slightly volatile
Income Tax Expense4.1 M4.2 M2.1 M
Slightly volatile
Non Operating Income Net Other96.8 K108.9 K118.9 K
Slightly volatile

Procept Biorobotics Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation38.4 M36.6 M9.5 M
Slightly volatile
Begin Period Cash Flow174.4 M299.3 M92.8 M
Slightly volatile
Other Cashflows From Financing Activities26.4 M14 M15.1 M
Slightly volatile
Depreciation3.6 M6 M2.5 M
Slightly volatile
Capital Expenditures7.5 M5.1 M7.2 M
Very volatile
Change To Operating Activities10.6 M10.1 M4 M
Slightly volatile
Total Cash From Financing Activities136.9 M207.1 M78.2 M
Slightly volatile
End Period Cash Flow233.1 M387.3 M133.9 M
Slightly volatile
Other Cashflows From Investing Activities40.6 M45.7 M49.9 M
Slightly volatile
Change To Netincome18.6 M17.7 M5.4 M
Slightly volatile
Sale Purchase Of Stock3.9 M4.1 M126.3 M
Slightly volatile
Cash And Cash Equivalents Changes163.4 M183.8 M200.6 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio20.4221.5152
Slightly volatile
PTB Ratio18.4712.033.2298
Slightly volatile
Days Sales Outstanding70.0312276.6291
Slightly volatile
Book Value Per Share4.926.943.3295
Slightly volatile
Stock Based Compensation To Revenue0.210.160.2597
Slightly volatile
Capex To Depreciation0.920.973.6171
Slightly volatile
PB Ratio18.4712.033.2298
Slightly volatile
EV To Sales19.1920.2149
Slightly volatile
Inventory Turnover1.111.41.2762
Slightly volatile
Days Of Inventory On Hand293270287
Slightly volatile
Payables Turnover5.277.846.0511
Slightly volatile
Research And Ddevelopement To Revenue0.30.321.5065
Slightly volatile
Capex To Revenue0.02150.02260.7452
Slightly volatile
Cash Per Share5.265.763.6299
Slightly volatile
Days Payables Outstanding48.4837.7161.1028
Slightly volatile
Income Quality0.790.981.0063
Slightly volatile
Intangibles To Total Assets0.00190.0020.0238
Slightly volatile
Net Debt To EBITDA1.752.781.2909
Slightly volatile
Current Ratio10.9110.438.6812
Slightly volatile
Tangible Book Value Per Share4.886.933.2722
Slightly volatile
Receivables Turnover5.273.095.1537
Slightly volatile
Shareholders Equity Per Share4.926.943.3295
Slightly volatile
Debt To Equity0.220.230.61
Slightly volatile
Capex Per Share0.130.07610.1878
Slightly volatile
Graham Net Net3.875.052.4452
Slightly volatile
Revenue Per Share4.073.881.2339
Slightly volatile
Interest Debt Per Share1.51.461.216
Slightly volatile
Debt To Assets0.290.170.3175
Slightly volatile
Operating Cycle389426368
Pretty Stable
Price Book Value Ratio18.4712.033.2298
Slightly volatile
Days Of Payables Outstanding48.4837.7161.1028
Slightly volatile
Ebt Per Ebit1.131.091.004
Slightly volatile
Company Equity Multiplier1.791.531.8939
Slightly volatile
Long Term Debt To Capitalization0.120.130.3371
Slightly volatile
Total Debt To Capitalization0.320.190.3675
Slightly volatile
Debt Equity Ratio0.220.230.61
Slightly volatile
Quick Ratio9.999.217.7375
Slightly volatile
Cash Ratio9.167.227.1816
Slightly volatile
Cash Conversion Cycle322378305
Pretty Stable
Days Of Inventory Outstanding293270287
Slightly volatile
Days Of Sales Outstanding70.0312276.6291
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.860.941.1096
Slightly volatile
Price To Book Ratio18.4712.033.2298
Slightly volatile
Fixed Asset Turnover4.654.431.8416
Slightly volatile
Debt Ratio0.290.170.3175
Slightly volatile
Price Sales Ratio20.4221.5152
Slightly volatile
Asset Turnover0.40.380.1728
Slightly volatile
Price Fair Value18.4712.033.2298
Slightly volatile

Procept Biorobotics Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap1.6 B1.8 B1.9 B
Slightly volatile
Enterprise Value1.4 B1.6 B1.8 B
Slightly volatile

Procept Fundamental Market Drivers

Procept Upcoming Events

27th of February 2024
Upcoming Quarterly Report
View
25th of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
27th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Procept Biorobotics Financial Statements

Procept Biorobotics shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Procept Biorobotics investors may analyze each financial statement separately, they are all interrelated. The changes in Procept Biorobotics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Procept Biorobotics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue11 M11.5 M
Total Revenue258.2 M271.1 M
Cost Of Revenue100.5 M105.5 M
Stock Based Compensation To Revenue 0.16  0.21 
Research And Ddevelopement To Revenue 0.32  0.30 
Capex To Revenue 0.02  0.02 
Revenue Per Share 3.88  4.07 
Ebit Per Revenue(0.39)(0.41)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Procept Stock Analysis

When running Procept Biorobotics' price analysis, check to measure Procept Biorobotics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Procept Biorobotics is operating at the current time. Most of Procept Biorobotics' value examination focuses on studying past and present price action to predict the probability of Procept Biorobotics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Procept Biorobotics' price. Additionally, you may evaluate how the addition of Procept Biorobotics to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY